rs1131690951
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_000455.5(STK11):c.374+1A>G variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000455.5 splice_donor, intron
Scores
Clinical Significance
Conservation
Publications
- familial pancreatic carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Peutz-Jeghers syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.374+1A>G | splice_donor_variant, intron_variant | Intron 2 of 9 | ENST00000326873.12 | NP_000446.1 | ||
STK11 | NM_001407255.1 | c.374+1A>G | splice_donor_variant, intron_variant | Intron 2 of 8 | NP_001394184.1 | |||
STK11 | NR_176325.1 | n.1641+1A>G | splice_donor_variant, intron_variant | Intron 3 of 10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.374+1A>G | splice_donor_variant, intron_variant | Intron 2 of 9 | 1 | NM_000455.5 | ENSP00000324856.6 | |||
STK11 | ENST00000652231.1 | c.374+1A>G | splice_donor_variant, intron_variant | Intron 2 of 8 | ENSP00000498804.1 | |||||
STK11 | ENST00000585748.3 | c.2+1A>G | splice_donor_variant, intron_variant | Intron 4 of 11 | 3 | ENSP00000477641.2 | ||||
STK11 | ENST00000593219.6 | n.*199+1A>G | splice_donor_variant, intron_variant | Intron 3 of 10 | 3 | ENSP00000466610.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Peutz-Jeghers syndrome Pathogenic:3
This sequence change falls in intron 2 of the STK11 gene. It does not directly change the encoded amino acid sequence of the STK11 protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. This variant is not present in population databases (gnomAD no frequency). For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant alters mRNA splicing and is expected to lead to the loss of protein expression (PMID: 15608654). ClinVar contains an entry for this variant (Variation ID: 428788). This variant has been observed in individuals with clinical features of Peutz-Jeghers syndrome (PMID: 12112668, 16287113; Invitae). -
- -
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.374+1A>G intronic pathogenic mutation results from an A to G substitution one nucleotide after coding exon 2 of the STK11 gene. This mutation has been identified in multiple individuals with Peutz-Jeghers syndrome to date (Resta N, Hum. Mutat. 2002 Jul; 20(1):78-9. Aretz S, Hum. Mutat. 2005 Dec; 26(6):513-9. Mehenni H, Dig. Dis. Sci. 2007 Aug; 52(8):1924-33.). Additionally, RNA analysis has demonstrated that this alteration leads to the use of multiple downstream aberrant 3' splice sites, causing various frameshift transcripts that translationally result in alternate stop codons (Hastings ML, Nat. Struct. Mol. Biol. 2005 Jan; 12(1):54-9.). Based on the available evidence, c.374+1A>G is classified as a pathogenic mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at